NCT03728049 - Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes | Biotech Hunter

Enrollment

944

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Aortic Valve StenosisAortic Valve Insufficiency

Interventions

DIAGNOSTIC_TEST

CT-ADP performed during TAVI procedure

The CT-ADP will be performed in the catheterization laboratory and revealed to the operator. The decision to undertake corrective procedure will be based on CT-ADP on top of standard methods of PVR assessment.

OTHER

No CT-ADP performed during TAVI procedure

PVR assessment with the standard methods only (TTE and/or angiography and/or hemodynamics but excluding TEE and CT-ADP). The decision to undertake corrective procedure will be left at the discretion of the operator.

Trial Locations (9)

33604

RECRUITING

Hopital Haut-Leveque - Chu - Pessac, Pessac

59037

RECRUITING

Institut Coeur-Poumon, CHU, Lille

Unknown

RECRUITING

Hopital Estaing - Chu63 - Clermont Ferrand, Clermont-Ferrand

NOT_YET_RECRUITING

Chu Montpellier, Montpellier

NOT_YET_RECRUITING

CHU de Nimes, Nîmes

NOT_YET_RECRUITING

Hu Pitie Salpetriere Aphp - Paris 13, Paris

NOT_YET_RECRUITING

Chru Rennes Site Pontchaillou, Rennes

NOT_YET_RECRUITING

Hopital Civil / Nouvel Hopital Civil - Strasbourg, Strasbourg

RECRUITING

CHU de Toulouse, Toulouse

All Listed Sponsors

collaborator

Siemens Healthineers, France

UNKNOWN

collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Lille

OTHER